Although the detection of BRAF p.V600E mutation by immunohistochemistry was clearly described in melanoma, discordant evidences were reported for the detection of p.V600K and p.V600R mutations. The aim of the study was to evaluate the efficacy of BRAFp.V600E, p.V600K, and p.V600R detection by immunohistochemistry in melanoma.
BRAFp.V600E, p.V600K, and p.V600R mutations in malignant melanoma. do they also differ in immunohistochemical assessment and clinical features / Ponti, Giovanni; Tomasi, Aldo; Maiorana, Antonino; Ruini, Cristel; Maccaferri, Monia; Cesinaro, Anna M; Depenni, Roberta; Manni, Paola; Gelsomino, Fabio; Giusti, Francesca; Garagnani, Lorella; Pellacani, Giovanni. - In: APPLIED IMMUNOHISTOCHEMISTRY AND MOLECULAR MORPHOLOGY. - ISSN 1541-2016. - 24:1(2016), pp. 30-34. [10.1097/PAI.0000000000000153]
BRAFp.V600E, p.V600K, and p.V600R mutations in malignant melanoma. do they also differ in immunohistochemical assessment and clinical features
RUINI, CRISTEL;PELLACANI, Giovanni
2016
Abstract
Although the detection of BRAF p.V600E mutation by immunohistochemistry was clearly described in melanoma, discordant evidences were reported for the detection of p.V600K and p.V600R mutations. The aim of the study was to evaluate the efficacy of BRAFp.V600E, p.V600K, and p.V600R detection by immunohistochemistry in melanoma.| File | Dimensione | Formato | |
|---|---|---|---|
|
Ponti_BRAFp.V600E_2016.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
536.58 kB
Formato
Adobe PDF
|
536.58 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
